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We investigated the hypothesis that keratinocyte-
produced platelet-derived growth factor-AA (PDGF-
AA) is involved in epidermal-dermal interactions and 
that PDGF-AA is an hnportant n~ediator of the tem-
poral and spatial events of tissue repair. Retroviral-
mediated gene transfer was used to introduce the 
gene encoding human PDGF-A into cultures of hu-
Dlan diploid keratinocytes. Genetic modification 
boosted the endogenous ill lIityo level of PDGF-AA 
secretion by over 300 fold. When PDGF-secreting 
cells were transplanted as epithelial sheets to athymic 
mice, modified keratinocytes underwent terminal 
differentiation and generated a stratified epithelium 
comparable to unmodified cells. Seven days after 
T he importance of cell interactions between epith e li al and m esenchymal units in the o rgan ogenesis of em-bryogenic ti ssue, as well as in th e maintenance of adult tissues, has been well studied in severa l o rgan system s, including the skin (fo r review see L 1]) . 
Keratinocytes, the principal ce ll type o f the epide rmis, synthesize 
and secrete a wide range of cytokin es that have potent and diverse 
effects on cell diffe rentiation, motili ty, and matrix synthesis [2,3]. 
Keratinocyte-produced cytokines could fun ction as e ith er autocrin e 
regulators of epiderm al growth and diffe rentiatio n o r as paracrine 
m edi ators o f epithelial-m esenchymal in teractio ns. 
Human dipl o id keratin ocytes can be seriall y propagated in 
cu lture and grown in to stratifi ed epi the lia that have been eva lu ated 
in the clinic for the treatment of va rious ski n de fe cts [4,5]. Limited 
clinical experi en ce suggests that sheets of cultured epi th elium may 
pro mote partia l regeneration of the dermi s w hen grafted to deep 
cutaneous wounds 1. 6,7] . The m echanism of this regeneration is 
uncl ear, bu t epidermal-derived cytokin es have been postulated as 
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Abbreviation : PPP. plate let-poor plasma. 
grafting the newly synthesized connective tissue 
layer subjacent to the PDGF-A-modified grafts was 
significantly thicker, was rich in mononuclear cells 
and fibroblasts, and had increased numbers of blood 
vessels when compared to control grafts of unmodi-
fied cells. These results suggest that PDGF-AA se-
creted by the epidermis is an important mediator of 
epithelial-mesenchymal interactions and helps to 
promote growth and vascularization of the underly-
ing dermal tissue. Further, these data den~onstrate 
the feasibility of using genetically modified cells to 
modulate tissue regeneration. Key woyds: gelle tmllsferl 
epideYlllal-mesellcl'yma.l sigllalillg/gyoII!tl, factors/tisslle re-
pai". ] [,west Del'llratol 105:756-763, 1995 
potenti al m edi ato rs [8] . The ro le of indi vidual epidermal-derived 
cytokines in this process as well as the ir ro le in the normal 
homeostatsis of th e skin is unclear. 
R ecently , it has bee n shown that p la te le t-derived growth f.,ctor 
(PDGF) is synthesized by keratinocytes ill normal epidermis, as well 
as at sites o f ac ute cutaneous ti ssue repair [9]. Unlike som e of the 
other epidermal deri ved cyto kines, the receptor for PDGF is not 
expressed by hum an ke ratinocytes; thus, epidermal-deri ved PDGF 
is a potentia l candida te for a paracrin e mediator o f the dermal repair 
process [10]. 
PDGF is a disulfide-linked dim er consi sting of two related 
po lypeptide chains (designated A and B) encoded by separate 
genes, and bio logicall y active PDGF occurs as e ither a homodimer 1 
(AA and BE) o r as a heterodimer (AE) (for review see [10]) . PD GF 
ac ts predominatel y on th e cell s of the mesenchym ye and expression 
of the PDGF receptor in the dermi s is markedl y up-regulated 
during the cutaneoll s wound-hea lin g process [9]. In addition to 
stimulating the proliferatio n of dermal fibrobla sts ['11] , smooth 
mu scle cell s \.1 2] , and microendotheli al ce ll s 1. 13], PDGF is chemo-
tactic for fibroblasts [11], macrophages [1 4, 15]' neu trophils 
[1 4, 15], and sm ooth mu scle cells [1 6] . 
To determine the ro le of keratillocyte-derived PDGF in epithelial-
mesenchymal interactions, we investiga ted the e ff"ects of PDGF-AA 
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over expre ssion in a transgenic e pide rmis. R e troviral-me dia ted g en e 
tran s f e r was use d to introduce the human PDGF-A ge ne into 
human k e ratinocyte s, and these modifi ed cells were g ra fted as an 
epithe lial sh ee t to athymic mice. Modifi e d cells o verexpressing 
PDGF -AA reconstitute d an e pide rmis simila r in appe arance to 
unmodifie d cell s. T h e m esen chy mal stroma subjacent to PDGF-A 
modifie d g ra fts showed a dramatic inc re ase in cellulari ty, vasc ular-
ity, and thickness. These results indicate that overexpression of 
PDGF-AA fro m the epide rrni s can induce sig nifi cant morphologic 
changes in the subjacent mesen chymal stroma, and may demon-
strat e the fea sibility of using g en e ti call y modifi ed cell s to modulate 
dermal repair. 
MATEIUALS AND METH O DS 
Reco:rnbinant Retrovirus A cDNA encoding human PDGF-A was 
amplifie d by po lymerase chain reaction using primers that created a BspH1 
site a t the transl atio nal start codon and introduced a BamH1 site after the 
transla tional sto p codon. The po lymerase chain reaction product was 
isolat e d after digesti on with BspH1 and BamH1 and inse rted in to the 
Ncol/B amH1 sites o f the retrov iral vector, MFG [1 7]. T he fideli ty o f the 
insert "'as verifi ed by DNA sequencing. To genera te a virus-producing ce ll 
line, MFG-PDGF-A plasmid DNA was transfected into the 'I'-C lUP 
pack aglllg cell line (o riginally obtained from R . MulEgan, Whitehead 
Institute of Biomedical R esearch, Cambridge. MA) as described [1 8]. 
Clo n es o f transfectants were isolated and screened fo r o ne producing the 
high es t titer. 
Keratinocyte Cell Culture and Viral Infection Normal human ke-
ratino cytes derived from neonatal fo reskins (strains 1- 5) were isolated and 
culture d following the method described by R.heinwa ld and Green [4] . To 
initia te primary cultures . keratinocytes were coculti va ted w ith 3T3-J 2 
' mo u se fib roblasts (originall y provided by H . Green. Harvard Medical 
Scho o l , Bosto n , MA) , pretl'eated wi th 15 /Lg/ml mi tom ycin C (Boehringer 
Mannhe im Co ., Indianapolis. IN) . C ulture media was changed every 3- 4 d 
with a 3:1 mixture o fDu lbecco's modified Eagle's medium (DMEM) (high 
gl uco se) (Gibco BRI., Gaithersburg, MD) , and H am 's F1 2 m edium (Gibco 
BRL) . Supplements were added as previously described [19]. Cells were 
! mbcultured by first re moving the feeder layer ~ell s with a brief ethylenedia-
mmete traace tl c aCId (EDT A) wash (5 mM 1I1 phosphate-buffered saline 
(PBS)) and then treating the keratinocytes with trypsin-EDTA. 
Swiss mo use 3T3-J2 and virus producing cells were ro utinely passaged in 
DMEM (high glucose) (Gibco BRL) , supplemented with 10% fetal bovine 
• serum (HyClone. Logan , UT) and penicillin-streptom ycin (1 00 IU / ml-l 00 
/Lg/ rnl, Boehringer Mannheim Co.). 
Keratinocytes were geneti ca lly m odifIed as previo usly described [20). 
I Briefly, preconAuent primary cultures were di ssociated , and cells were passed to a dish containing mitomycin C-treated (15 /Lg/ml) vlrus-pro-
I ducing ce ll s. Four to six days after co-cultivation. modifi ed cell s were 
dissocia ted and parallel cultures were prepared fo r pro te in analysis, DNAI 
, RNA i sola tion , grafting, and plating e ffi ciency. Unmodifi ed control cell s 
were c ultll.red on 3T3-J2 cell s. 
T h e g row th of modifi ed versus contro l kera tinocytcs was m casured by 
plating k eratinocytes (5 X 105) in 60-mm dishes containing feeder cells and 
determining viablc cell number by trypan blue staining at days 3,5,7,9, 11 , 
13, and 15 of culture. Cell counts were perfo rmed by fi rst remo ving thc 
I fibroblas t feeder layer cell s wi th a brief EDTA wash (5 mM in PBS) and then treating the keratinocytes with trypsin-ED TA to obtain a single cell 
suspen sio n. 
PDGF-AA Time Course Modified keratinocytes (1 0(') were pla ted onto 
a 10- c rn. dish and grown to conAuence (107 cell s/10-cm dish) . Fresh m edia 
were added (30 ml) and portions (1 ml) of the culture medium were 
removed over a 4-d period. Samples were brieAy ccntrifuged at 15.000 X g, 
I and the supernatant was assayed for hPDGF-AA by cnzyme-linked immu-I nosorbe nt assay (ELISA) (Quantikine Human PDGF-AI3 Immunoassay , 
I R&D Systems, Minneapolis. MN) . T he assay was calibrated with rhPDGF-I AA (Boehringer Mannheim Co. ) , and the lower limit of scnsitivity of the 
ELISA fo r PDGF-AA was determined to be 200 pg/ml. PDG F-AA prote in I produ c tion was normali zed to cell number and medium conditioned by 
unmodified keratinocytes was used as a control. T he rate o f protein 
synth esis was detemlined by averaging the daily rate of pro tein synthesis 
J over a 4 -d period . 
I Southern and Northern Blot Analysis Total genomic DNA was 
ilola te d fro m conAuent culturcs of modified and control kcratinocytes and 
10 J,Lg w as digested wi th Kpnl . The digcs ted DN A was fractionatcd by 
agarose gel electropho resis, transferred to a nylo n filter, and analyzed by 
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Southcrn blot hybridiza tion using a 32P-Iabcled PDGF-A probe. As a size 
standard and an estimate of the e friciency of gene transfer, 10 pg of 
MFG-PDGF-A plasmid DN A (equivalent to a single gene copy) was 
diges ted along with 10 /Lg of control DN A and included on the Southern 
blot . 
T o tal cellular RNA was isolated fro m conAuent cultures of m odi fed and 
control kera tinocytcs by the guanid inium isothiocyanate method and frac-
tiona ted by electro phoresis in a dena turing formaldehyde-agarose gel. T he 
fractio nated RNAs were blotted onto a nitrocellulose filter and hybridized 
w ith a 32 P_Iabelcd PDGF-A probe. 
Bioassay for PDGF The bioactivity of PDG F-AA secreted by m odified 
keratinocytes was dete rmined using a m odi ficatio n of a cell proliferati on 
assay m easuring the stimulation of [3H)thymidine incorporation [21) . 
Modified kcratinocytes secre ting PDG F-AA were grown to conAuence in a 
10-cm culture dish , rinsed w ith se rum-free D M EM , and incubated wi th 5 
ml DMEM containing 5% platelet- poor plasm a (PPP) and penicillin-
strepto mycin. O ne-milliliter aliquots of conditioned culture m edium con-
ta ining kera tinocyte-produced PDGF-AA werc sampled at 2, 4, 10, and 24 
h. Medium with 5% PPP alone or conditioned for 24 h by unmodi fied 
kera tinocytcs was used as background controls yie lding similar levels of 
['H]thymidine incorpora tion. T he abili ty o f keratinocyte produced 
PDG F- AA to stimulate cell proliferatio n w as m easured by [3H]thY111idine 
incorpo ration o f quiesccnt Swiss 3T3 ce ll s. Quiescent Swiss 3T 3 cell s wcre 
incuba tcd wi th cond itioned media from modified keratinocytes wi th or 
without neutralizing antibody to hPDGF-AA (50 /Lg/ ml final concentra-
tio n , R &D Systems) for 12 h (37°C . 10% CO2), T he Swiss 3T3s were 
w as hed with se rum-free DM EM and incubated fo r 20 h w ith [3H]thymidine 
[ (1 /LC i / w ell in D ME M (5% PPP)] (Du Pont Company. \Xl ilmington. DE). 
Cell s were washed in serum-free DME M and DNA was precipitated with 
tw o w ashes of5% trichlo roaceti c acid at 4°C and cells were Iyzed w ith 0.6'1., 
sodium dodecylsul f.1te. T richloroacetic acid- insoluble m aterial was har-
vested on a glass fi ber filter and counted in a scin ti ll ation counter (Packard 
Instrument Co .. Meriden. CT) . A standard curve was established by 
incubating quiescent Swiss 3T 3 ce lls wi th D M EM 5% PPP supplem ented 
with 5, 10, 20, and 100 ng/ml rhPDGF-AA (Boehringer Mannheim Co.). 
Grafting Modified Epithelia to Athymic Mice Graftin g was per-
for med using 6 - 8-week- old NIH Swiss 1/1/ 111/, mice (Taconic Farms, 
Germanto wn , NY) anes theti zed w ith an intrape l-itoneal injection of 2,2 ,2,-
tribrom oethano l (0 .58 mg/g body weight) (Aldrich , Milwaukee, WI). 
C ultures o f conAuent keratinocytes (35 mm) were washed tw ice wi th 
serum-free DMEM, detached as an intact epithelium with D ispase II 
solutio n (1 .2 U / ml , 1 h , 37"C) (Boehringer Mannheim Co.) and grafted to 
athymic mice as described by Barrandon [1 9]. BrieAy, the detached 
epithelium was placed basal side up on a sm all piece of Silastic m embrane 
(thickness 0.005 inches) (Dow Corning . Arlington, T N). T his graft was 
inserted under a full- thickness skin Aap o n the back of the m ouse so that, 
whcn the Aap was closcd . the basal side of the epithelium came in con tact 
w ith the inner side of the m ouse skin . Before inserting the epithelium. the 
loose connective tissue covering the inner side of the Ill0 U Se Slcill \-vas 
removed by di ssectio n. In thi s w ay, the basal side of the epithelium was 
placed directly o n the panniculo us carnosus. T he incision was closed wi th 
surgica l clips and animals were caged separately. Grafts were harvested 7 d 
:t fter grafting. Pre vious studies have sho wn that by day 7 a complete 
epithelium has formed [19) and clinical studies have shown that by tins tim e 
:t "neodermis" begins to fo rm (6,7). 
Tisslle Extracts Epithelium generated fro m modifi ed and co ntrol kera-
tinocytes w as harvested 7 d after grafting by dissecting the epithelium free 
of connecti ve tiss ue and "snap-freez ing" the tiss ue in liquid ni troge n. T he 
frozen ti ssue w as po wdered and resuspended in 400 /.d of 25 mM Tris buffe r 
(pH 7.5), containing 1 mM EDTA. T he tissue was sonically disrupted for 10 
seconds at 50 W and the suspension was centrifuged fo r 5 min at 15,000 X 
g. T he supernatant was assayed fo r hPDG F-AA by ELI SA (R&D systems). 
The size o f the graft w as measured by tracing the outline on the Silas tic 
I11CI11branc. 
Histology Seven days afte r grafting, the human epithelium and subjacent 
mo use tiss ue were harves ted for hi sto logic analyses. The tissue was e ither 
fi xed in buffe red formaldehyde o r immediately fi'ozen and stored at - 70°C 
ulltil cryoscctioned. Parafrin-ernbedded sectiolls (5 /Lm ) were stained for 
hCIl1atoxylin-cos in . 
T he thickness o f the mo use connecti ve tiss ue layer, subjacent to the 
human epithelium . w as determined by image :tnal ysis using the Image 
Analysisl Acquisitio n So ftw are systcm (Uni versa l Image Corporation , 
W estchester, PAl coupled to a Nikon Diapho n 300 microscope (N ikon , 
Melvillc , NY) . T he edges of the epithelial grafts were avoided as these 
showed signs o f hyperproliferati on . The cross-scctional area of the m ouse 
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connective tissue layer, subjacent to the human epithelium, was determined 
for 15 fields of view per graft . The thicknesses were calculated by dividing 
the area by the known length of sample of the field of view (400 /Lm). 
Thickness measurements for control (nine grafts) and modified grafts (ten 
grafts) were made from a total of 54 and 60 mm linear lengths of graft, 
respectively. Statistical comparison of modified and 11IUnodified grafts was 
performed using the Student t test f~r unpaired samples. 
Immunohistochemistry To detect the presence of laminin and Factor 
VIII-related antigen , cryostat sections (6 /Lm) were fixed in acetone for 5 
min, placed in H zO z (0.3%) for 15 min, and then blocked with blocking 
solution (3% bovine serum albumin, 1% normal goat serum, 0.02% Na azide 
in PBS) for 1 h at room temperature. Sections were incubated with the Ig 
fraction of a rabbit anti-human Factor VIII-related antigen serum (Bio-
Genex Laboratories, San Ramon, CAl or an affinity-isolated polyclonal 
rabbit anti-mouse-Iaminin antibody (1 :400) (Sigma) for 1 h at room 
temperature. Slides were washed 4 X 15 min in PBS and incubated with 
Auorescein-conjugated affmity-purified goat anti-rabbit IgG antibody (1 :50) 
Oackson ImmunoResearch Laboratories, West Grove, PAl for 1 h at room 
temperature. The slides were coverslipped using 1% n-propyl-gallate 
mounting solution (Sigma). All antibodies were diluted in blocking solu-
tion. Control sections were not exposed to primary antibody. 
RESULTS 
Genetic Modification of Human Keratinocytes The struc-
ture of the recombinant retroviral vector used to express the 
PDGF-A gene is shown in Fig tA. T illS vector, MFG, is derived 
from the Molony murine leukemia virus and contains the genetic 
elements necessary for the transcription, packaging, and reverse 
transcription of the recombinant RNA as well as the integration of 
the recombinant provirus into the genome of the target cell. A 
cDNA encoding human PDGF-A was inserted into the MFG 
vector, which was then transfected into the 'I'-CRIP packaging cell 
line . A clone of the 'I'-CRIP packaging cell line producing the 
MFG-PDGF-A recombinant virus was isolated. Recombinant virus 
produced by the 'I'-CRIP cells are free of detectable replication-
competent virus and have an amphotropic host range. 
Secondary cultures of human keratinocytes were genetically 
modified by co-cultivation with mitomycin C-treated 'I'-CRIP 
cells producing the MFG-PDGF-A virus. After 4 d of cocultiva-
tion, the virus-producing cells were removed and the keratinocytes 
were dissociated and passed onto plates containing a normal 3T3 
fibroblast feeder layer. 
The MFG-PDGF-A recombinant retroviral genome was de-
tected in the cellul ar DNA of modified keratinocytes by Southern 
blot hybridization. High-molecular-weight DNA prepared from 
modified and control keratinocytes was cleaved with Kpn I and 
transferred to a nylon membrane after fract ionation by gel electro-
phoresis. Because Kpn I cleaves three times in the MFG-PDGF-A 
recombinant genome, once in each LTR and once upstream of the 
PDGF-A insert, it excises a 1300-base pair fragment containing the 
PDGF-A cDNA. H ybridization with 32P-labeled PDGF-A gene 
sequences revealed the presence of the MFG-PDGF-A fragment of 
correct size in the cellul ar DNA of modified cells (Fig tB). When 
compared to the hybridization signal from a sin gle gene copy 
standard of the MFG-PDGF-A plasmid DNA, the efficiency of 
transduction of the cell population was estimated to be greater than 
50%. 
Genetically Modified Human Keratinocytes Secrete 
PDGF-AA Transcription of the MFG-PDGF-A provirus was 
verified by Northern blotting of total cellula r RNA isolated from 
modified ceUs (Fig tq. After hybridization with 32P_labeled 
PDGF-A gene sequences the expected transcripts from the MFG-
PDGF-A provirus were detected in total ce llular RNA isolated 
from modified cells. Using total cellular RNA, endogenous PDGF 
mRNA was undetectable. 
Secretion of PDGF-AA protein into the media by modified 
keratinocytes was measured by ELISA. PDGF-AA protein was 
continuously secreted by modified keratinocytes for up to 4 d (Fig 
2) at an average daily rate of744 ng/l07 cells124 h . In contrast, the 
rate ofPDGF-AA secretion ofu1Ull0dified epidermal cells was 2.1 
ng/l07 cells124 h (data not shown). Compared to the endogenous 
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Figure 1. Integration and transcription of recombinant retrovirus. 
A) Proviral structure of MFG-PDGF-A recombinant retrovirus and ex-
pected R.NAs is diagrammed. Shown is the LTR. long termina l repeat; SO. 
splice donor; SA. splice acceptor; \1/ + , packaging signal and sites of digestion 
with Kpnl . B) Southern blot of cellular DNA (10 /Lg) isolated fi'oll1 control 
keratinocytes (unmodified) (Inll c "/) and MFG-PDGF-A-modifed keratino-
cytes (/nlle 2). DNA was digested with Kpnl and probed by hybridization to 
a 32 p-hPDGF-A probe. Shown arc size markers. C) Northern blot of total 
RNA (5 /Lg) isolated from control (In lle 1) and MFG-PDGF-A-transduced 
keratillocytes (Inll e 2) . Filter was hybridized with a 32 p_hPDGF_A probe. 
Shown are the rRNA mOl·kers. 
level of PDGF-AA secretion by unmodified keratinocytes, genetic 
modification boosted hPDGF-AA secretion by over 300 fold ill 
IJjtro. 
The biologic activ ity of PDGF-AA produced by modified kera-
tinocytes was measured using a bioassay. Condi tioned media from 
modified keratinocytes were harvested at various times (2, 4, 10, 
and 24 h) and tested for their ability to stimulate the incorporation 
of eH]thymidine into quiescent Swiss 3T3 cells (Fig 3) . When 
compared to contro l media £i'om unmodified keratinocytes, media 
from modified ce ll s showed a dose-dependent stimulation of 
eH]thymidine uptake and tillS activity increased the longer the 
media was conditioned by modified cells. Medium conditioned for 
24 h induced a threefold increase in [3H]thymidine incorporation 
over medium conditioned by control cells. T his activity in the 
conditioned media from modified cells could be inlllbited to 
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Figure 2. Modified keratillocytcs secrete PDGF-AA. A time course of 
PDGF- AA secretion was determined by rcmoving portions of the culturc 
medi um of a confluent culture of modified keratinocytes as indicated over 
a 4-d period and hPDGF-AA was measured by ELISA. 
background levels by addition of a neutralizing antibody to PDGF-
AA. Moreover, when the leve l of PDGF-AA in conditioned media 
was quantitated by ELISA and compared to the bioactivity of 
purified recombinant PDGF-AA in the bioassay, the keratinocyte-
prod u ced PDGF-AA had a specific activity comparable to the 
purified recombinant protein. Half-maximal stimulation of 
eH]thymidine incorporation was achieved with 22 ng/ ml of 
recornbinant PDGF-AA and 30 ng/ ml of keratinocyte-produced 
PDGF-AA. 
P DGF-AA Secretion Does Not Alter Keratinocyte Growth 
To d e te rmine if genetic modifica tion had altered the growth 
properties of m odified cells, the growth of PDGF-AA- secreting 
cells vvas compared to unl110dified cells. Equal numbers of cells 
were plated and at various times over a 15-d period viable ce lIs 
were counted u sing trypan blue. The growth rates of PDGF-AA-
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Figure 3. Keratillocyte-produccd PDGF-AA is bioactivc . Culture 
mediUlTI conditioned by kera tinocytcs secreting PDGF-AA was harves ted in 
DMEM 5% PPP at 2, 4, 10, and 24 h of incubation and PDGF-AA levels 
measured by ELISA. Increasing doses of keratinocyte-produced PDGF-AA 
were an'i1 yzed for the abi li ty to stimulate [' Hlthymidinc incorporation into 
qujescent Swiss 3T3 cell s. Also tested in the assay were DMEM 5% PPP 
harvested after 24 h fi'om unmodified ce lls and increasing doses of 
recombinant purified hPDGF-AA in DMEM 51yo PPP. Background levels of 
DMEM SIX, PPP alone or conditioned by unmodified cells for 24 h were 
similar. All samples were tested without or with a ncutralj zing polyclonaJ 
antibody to hPDGF-AA. [' H)thymidinc incorporation into trichloroacetic 
acid-insoluble material was determined and the mean ± SEM fo r trip licate 
samples is presented . 
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Table I. Genetically Modified Keratillocytes Express 
PDGF-AA III Vivo 
PDGF-AA Area of graft 
Strains" (ng/graft)/ (nll11 2) 
Control 
4 nunlbcr 0 54 
4 number 2 0 78 
5 0 59 
Modified 
4 number 1 2.45 90 
4 number 2 0.4 58 .5 
5 0.85 72.5 
;, Tissue cxtr:IC( was made of hUI11 :111 epidermis gcncr:ncd frol11 unmodified or 
MFG-PDGF-A trn l1sd l1 ccd kcratinoc),ccs 7 d after grafting. 
/, PDGF-AA was deterlllined b)' ELI SA. 
secretin g cells ve rsus unmodified contro l cells were comparable 
over the time tested (data not shown) . 
Keratinocytes Secreting PDGF-AA Promote Connective 
Tissue Formation When Grafted to Athymic Mice Kerati-
nocytes secreting PDGF-AA were tes ted for their ability to form an 
epidermis when transplanted to an athymic mouse. Normal o r 
m odified keratinocytes were grown to conAuence in a 35-l11.m dish. 
The epithelial sheet was detached using Dispase and grafted to the 
underside of a dorsal skin Aap. The basa l side of the sheet was 
placed directly on the p annicuious cal'nosus. Seven days after 
grafting the human epithelium and the subjacen t m ouse ti ssue were 
fixed and stained . 
The PDGF-AA content of grafts from two separate strains was 
m easured to confirm that the PDGF-A gene was expressed ill II i llo. 
Tissue extracts of 7-day-old grafts dissected fi'ee of connective 
tissue were prepared and levels of PDGF-AA w ere de termined by 
ELISA. PDGF-AA in wlmodiiied grafts was undetectable, whereas 
modified g rafts contained on average 1.2 ± 1.1 (mean ± SD) 
ng/ graft. The average area of unmodified and m odified grafts was 
64 ± 12.7 (mean ± SD) mm2 and 73 ± 15.8 (mean ± SD) 111m2 , 
respective ly (Table I) . Variability in the am ounts of PDGF-AA 
between grafts is probably due to variability in the extraction 
procedure rather than different levels of production ill IIillo . AJ-
though these data can not be used to de termin e if the sam e high 
level of ill vitro PDGF expression is m aintained afte r transplantation, 
it does indicate that the PDGF-A gene is active ill vill o. 
Both control and PDGF-A expressing keratinocytes developed a 
stratified epidermal structure severa l celI laye rs thick that contained 
stratul11 granulosul11 and stratum corneum (Fig 4A,B) . T hese 
differentiated layers are typica lly absen t in cultured epithe lium and 
their presence in the g rafts indicates 1110re complete terminal 
differentiation . Overall , the m orpho logy of the epidermis formed 
by modified keratinocytes was indistinguishable £i'om grafts of 
control celIs . 
A lthough the epithelium of control and PDGF-A expressing 
grafts were comparable , the connective tissue layer subjacent to the 
grafts (between the panniculous cam osus and the human epithe-
lium) showed significant differences . The tissue subjacent to control 
epithelium contain ed fibrob lasts and mononuclear cells distributed 
within a loose connective tissue w ith occasional blood vessels. 
Compared to control grafts, the connective ti ssue layer subjacent to 
the PDGF-A grafts had increased numbers of fi broblasts and 
mononuclear cells and, in the majority of grafts (e ight of 10). 
greater numbers of blood vesse ls (Fig 4A,B) , In control and 
PDGF-A- expressing grafts, the collage'n fibers of the conn ective 
tissue were uniformly distributed and oriented in paralle l to the 
overlying epithelium . Fibers in PDGF-A grafts appeared thicker 
and more densely organized. W ithin the subjacent tissue for contro l 
and PDGF-A- expressing grafts there was a gradient of cellulari ty 
and connective tissue densi ty. with the highest density closest to the 
epithelium. 
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F igure 4. The cellularity/vascularity of the connective tissue snbjacent to PDGF-AA-secreting grafts is enhanced. C ultures of cOIIAuetlt 
epitheli a genera ted frum unmo difi ed (A, C, E) ur MFG-PDG F-A-transduccd kc r<lti nocytcs (B, DJ P) were dctrlcitcd fr0l11 the di sh w ith Dispasc treatment 
a nd grafted under a fu ll- thickness slcin Rap of athymic mice. Seven days late r the grafts were f.xed in bufFered fo rmaldehyde and paralti n- ernbedded sections 
(5 /-I.m thi ck) stained w ith hematoxylin and eos in (A . B) . O ther grafts were frozen and cryoscctions were stained using a rabbit antibody to human Factor 
VIII-related antige n (C, D) or a rabbit antibody to mo use laminin (E, F). Stainjng for bo th antibodies was visualized with a Au o resccin-conjugated 
alti ni ty-pu ri fied goat-anti-rabbit IgG antibod y. he , human epidermis; ct, connective tissue; pc, panniculus ca rn osus (bnr, 100 /-I.m). 
PDGF-A- Expressing Grafts Induce Neovascularization 
The increase in vascularity of PDCF-A- express ing grafts was 
confirmed by immunohjstochemi ca l staining for Factor VIlI-re-
lated antigen and laminin . Factor VIII-related antigen is present in 
endotheli a.! ce lls and p.!atelets [22], whereas laminin is present in the 
basement membranes of skin, blood vessels, and l11uscle [23]. 
VOL. l OS . NO. (, D ECEMI3 Elt 1995 
strain 3 strain 4 strain 5 
400 
-
300 E • • :j,. 
-
en 
en 200 Q) 
~ ~ .* 
--+-
• • 
• • 
c 
~ 
u + • 
--:r: 
I- 100 
• + • 
Figure 5. The thickness of the connective tissue subjacent to 
PDGF-AA-secreting grafts is enhanced. Grafts of control and PDG P· 
AA- ovcrexpress ing ce lls generated from three separate strains of diploid 
kerati n ocytcs we re transplanted to athymic lni cc . The thi ckness o ftll c ti ss ue 
subjacent to the 7-day-old grafts was measured by image ana lysis of 
henlatoxylill and cosin-stained sectio ns. For a field of view, th e area of the 
mo u se cOTln ective t iss li e layer subja cent to th e hU111 :l 1l c pithcliu1l1 \:vas 
detennincd ,l1ld the thi ckness C0T11plltcd . M casurClllcl1ts were tak e n for 15 
fie lds of view per g raft nud each point rep rese nts O IlC graft. Fro m each gro up 
the ITICa n is prese nted. *p < 0 .02; srrn in 3. II = 8; strain 4, n = 7: strain 5. 
n = 4 . 
In the subj acent tissue of a control g raft, stalJ1 l11 g for Factor 
VIII-re lated antigen was nea rl y absent (F ig 4Q. In contrast, 
staining for Facto r VIII- re la ted an tigen was abundant thro ugho ut 
the connective tissue laye r subjacent to the PDGF-A- expressing 
graft, t hu s identifying the presence of capillaries and! o r small er 
blood vesse ls (Fig 4D) . Staining fo r laminin confirmed this in crease 
in vasculari ty of the PDG F-A- expressing graft over control g raft. 
Control and PDGF-A- express ing gra fts contained strong stainin g 
for l a lTlinin in th e basem ent m embran es o f the epide rmal-dermal 
junction as w e ll as around the panniculo us cal'l1OSI1S (Fig 4E,F) . 
However, within the connective tissue laye r, Iaminin sta ining for 
the ba sement membran es of blood vesse ls was abund,lI1t on ly in the 
connectivc tissue of the PDGF-A-express ing g raft. 
PDGF-A-Exprcssing Grafts Incrcasc thc Thickncss of thc 
Subjaccnt Conncctive Tissuc Laycr T he cellular and vascul ar 
response of modifi ed grafts was accompa nied by a stroma l thick-
ening of the connective tissue layer deve loped adjacent to the g rafts 
(Fig 5). T he thickness of the subjacent conn ective tissue of control 
versu s PDGF-A grafts was measured by im age analysis fr0111 threc 
diffe t'ent sets of grafts, using three dilfercnt strains ofkeratin ocytes. 
Tn each experimcnt. the connective tissue subjacent to thc PDGF-A 
grafts 'Was signifi cantl y thicke r than con tro l grafts (p < 0.02). The 
average of the inCl'ease in thickness for all the grafts of the three 
stra in s wa s 68'X, w ith a low of 5'\ % and a h igh of 1 00%. 
D ISCUSS IO N 
In this s tudy we in vestiga ted the rol e of epidcl'Il1al-produ ced PDGF 
on c u tan cous tissue o rga nization by overexpress ion of the hum,lI1 
PDCF-A genc . Hum an diplo id keratin ocytes w ere geneticall y 
modifi e d with a recombin ant retrovirus expressing the PDGF-A 
gene, and cpithe lial sheet grafts generated from PD G F-AA-secre t-
ing kerati nocytcs w ere transplan ted to athymic mice. T he in tegra-
tion a nd express ion of the PDGF-A gene was characterized by a 
series of ;1I /1;11'() ex periments. Integration and transcription of the 
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PDGF-A recombinant retrovirus in transduced keratinocytes was 
veri fied by Southern and North e rn blo t hybridi za tion. respective ly. 
T he level of PDG F-AA protein secreted by m odifi ed keratinocytes 
was m casured by ELISA and genetic m odifi cation boosted the ;11 
";1,.,, level of PDGF- AA secretion by over 300 fo ld. PD GF- AA 
protein secreted by modified ke ratin ocytes was bio logically active 
wh en tested in an ;11 11;lm pro li fe ration assay. 
Epi the lial sheets of con tro l and PDG F-AA-secreting keratino-
cytes were transplanted to athymic mice . A stra tified cpidermis. 
complete w ith stra tum granulosulll and stratulll corncum. was 
fo rm ed ill 11;1/(1 for bo th contro l and PDGF-A-overex press ing ce ll s. 
PDGF-A overexpression did not appear to have any maj or alfects 
on the te rmin al dilfe rentiation of the ke ratinocytes. H owever. 
PDGr--A overexpress ion did havc an influence on the strom al tissue 
subjacent to the g rafts. When compared to con tro l g rafts, the 
stromal ti ssue subj acen t to thc PDGF-A- express ing g rafts was 
thicke r, had a g reater ce ll density of fibrob lasts and m ononucl ea r 
ce ll s, and had signi fica ntly m o re blood vesse ls. T he increase in 
vascu lari ty of the subjacen t ti ss ue was con fi rmed by sta inin g for 
Factor VIII-re lated an tigen and lam inin. 
T hese results support the conclusio n that PDGF-AA protein 
produced by the epidermis is like ly not an autocrine regul ator of 
epide rmal g rowth and differentiation but rathe r a parac rine m edi -
ator of the adjacent m esenchymal tissue. In o ur grafts of PDGF-A-
express ing cells, many changes w ere evident in the mesenchym al 
ti ssue, including in creased numbers of fib ro blasts and m o nonu clear 
ce ll s as w e ll as an in crease in vascul arity . Most of these changes arc 
readil y explained by the h.'ll own ;11 II ;I /'() activ ities of PDGF- AA 
protein. Although typ ica lly less poten t than PDGF- BB. PDGF-AA 
stimulates pro lifera tion of fibro bl asts [1 1] and migration of fibro-
blasts [111 , macrophages, and neutro phils [1 4]. T hus, PDGF- AA 
secreted fro m the ep idermis m ay act as the primary m edi ator of 
thesc cellular changes in thc m esenchym al tissue. 
O ne chan ge in the mesen chym c not rea dil y explained by the ;11 
,,;Im activ ities o f PD GF-A A pro te in is thc in crease in vascul ari ty. 
PD GF-AA protein is not directl y mitogeni c fo r endothe lia l ce lls ;11 
,,;11'0. However, recentl y it has been shown that microvascul ar 
endo the lial ce lls express mRN As for both PDGF rccepto r subuni ts 
a and f3 l1 3] . Purified PDGF-BB and , to a lesser exten t. PDGF-AB 
were mitogenic fo r microvascul ar endothe lial cell s ill 11;lro. But 
PDGF- AA fi,i led to indu ce any endothe lial pro li feration desp ite the 
fact that PDGF-AA induced receptor au tophosphorylation [1 3 1. 
T his block to PD GF-AA-media ted prolife ration m ay not be true for 
endothe lial ce ll s ill ";'J() because othe r cytokin es or f.,cto rs m ay be 
opera tive ;11 " ;110 tha t faci litate a response to PDGF-AA. For 
example, epidermal keratinocytes arc kn own to synthesize and 
secre te relat.ively high levels of vascu lar endo the lial growth facto r. 
which docs stimu late the proliferation o f endothe lia l ce ll s ;11 ,,;Im 
and ;11 11;110 124]. Other cytokines produ ced by the epidcrmis with 
angiogenic activity are basic fibro blast growth fi,cto r [25] and 
transfo rmin g growth facto r a (TGF-a) 126,27]. T hu s. PDGF-AA 
expressed fi'om o ur modified g rafts may act synergistica lly w ith 
other epide l'lnal-produced cytokincs to stimulate vascularization in 
this m ode l. 
Alternatively, the ;11 ,1;,,,, actions of PDGF- AA m ay be indirect. 
T hose cells in the strom a th at ha ve in creased in number due to 
PDGF-AA-mediated pro li feration o r mig ration could produce 
gro wth facto rs that arc angiogenic. In o ur m odel, increased num-
bers of macrophages and fibrobla sts could resul t in increased 
produ ct io n of speciti c endo thelial cell mitogellS, such as basic 
fibro blast growth factor l28 .29]. Simil ar eR'Ccts have been desc ribed 
fo r TGF- f3. w hich. althou gh inhibito ry to the gro wth of' endothe lial 
ce lls ill Il ilm. is an in ducer of angiogenesis ;11 "i"o 130] . Anothe r 
poss ibility is that PDGF-AA co uld sti ll1lil,ate cells to express cyto-
kines that promote angiogenesis. PD GF- AA has been shown to 
stimulate the production of insulin-like growth factor- l from 
fib roblasts [31 1. Likewise. PDGF-A A induces the ex press ion of J E 
and KC in mo use fibrobla sts, two proteins chem otactic for m ono-
cytes and neutrophils. respective l)' 132 1. R egard less of the m echa-
ni sm. our data support thc concl usion tha t PDGF-AA protein 
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is an important p3Tacrine signal produced by the epidcnllis to affect 
changes in the subjacent mescnchrrn:d tissuc. 
A role for epidermal-derived PDGF-AA in cpidermal-mesenchy-
mal signaling has also been postulated from studies of mouse 
devclopmcm. Ju situ hybridization of normal e mbryos demon-
strated that PDGF-A and its receptor (a) are expressed in separllte 
but adjacent cell layers. The ligand is expressed in the epithelium 
and the receptor is expressed in the adjaccllf mescncJlymc [33]. t 
Parch (Ph) is a recessive embryonic lethal mutation in the mOllse 
and is associated with OJ large genomic deletion encompassing the 
gene encoding the a-receptor for PDCF [341. In affected mice 
(Ph/Ph) mcsodcnnal components of the skin fail to develop. 
resulting in a skin with no dermis and an unorganized epidermis 
P5). These data also support the conclusion that PDGF-AA 
produced by the eptheliulll is a paracrine signa l for [he adjacent 
l11 t:!sem.:hYllle and parLicip<llCS in lh!::. ..:ontrol of skill organogenesis 
during deveiopm enL 
Similar questions regarding the paracrine ve rsus aucocrine role of 
cytokines produced by the cpidenllis have been addressed using 
transgenic anim als. In this approach. cytokincs linked CO a keratin 
promoter were overexpressed in tbe stratified squamous epithelia of 
t ransgenic mice. These studies suggest that TGF-a and TGF-t3 
produced hy [he epidermis are important aucocrine m ediacoTS of 
epidennal ho meostasis [36,37J. Overexpression ofTGF-a induced 
hypertrophy of the epidermis, whereas ovcrcxpression of TGF-fJ 
severely inhibited epidermal growth. Although TGF-a and TGF-13 
' have strong effects on connectivc tissue cells it! J,;tro , the effects of 
overexpression of these cytok:ines on the dennis of these n:ansgenic 
mice was minimal. None of these transgenic animal studies ha ve 
demonstrated the control of the dennis by paracrine signals ema-
nating from the epidermis [36-38]. 
I[ is noteworthy th:1t rhe approach used in our studies can serve 
as an aitemate mcrhod for generating animals with a transgenic 
epithelium. Diploid human keratinocyres. which cm1 be serially 
propaga ted itl l'itfCl and genetically modi£cd, will form a differen-
tiated epidermis after transplantation. Thus, we arc able to examine 
the effects of traosgene expression in a l1tunan tissue and the 
rransgcnc expression is confutcd to a specific tissue. Moreover. we 
are able to attain relatively high levels of transgel1.c ex pression and 
these levels ean be controlled in future experiments by preparing 
g rafts with different ratios of modified and unmodified cells. This 
transgcllic approach facilitates [he study of transgcne expression in 
adult tissue and avoids the problems of embryonic Icthalmutations 
or a bias in expression levels that can occur whcn some transgcnes 
are introduced into the mouse gcnome. Because integration of the 
recombinant retroviruses is random and there are multiple integra-
tions in the cell population (>105). the problems associated with 
position effects on single transgcne intcgrants arc also avoided. 
Lastly, retroviral-mediated gene tnmsfer can readily be used to 
geneticall y modify primary keratinocytes derived from numerous 
biopsies thar will rule Out any cell strain-specific effects. 
Cultured cpithelial sheets of allogeneic ce LIs have been tested in 
the clin ic for the repair of various defects of the skin, including bum 
wounds. split- thickness do no r s i tes. and chronic venous and decu-
bitus ulcers (revie '\vcd in [5]), The take of these cultured alJografts 
was temporary. lasting only 7-14 d [39]. but seemed to promote 
Some healing (40]. It h:'l s been hypothesized that these temporary 
allografts promote healing by i) acting as an occlusive dressing, ii) 
syn thesizing low levels of endogeno us growth facto rs. and iii) 
synthesi zing extracellular matrLX molecules. 
Our data with PDGF~A-ovcrexpressing cells supports the hy-
pothesis that cytokincs produced from cultured epithelial grafts can 
influence the ti ss ue-rcgeneration process and would suggest thac 
PDGF is potentially an important mediator because it.s actions arc 
directed to the underlying mesenchymal tisslle . One potential 
application of our approach would be thc development of a 
geneticall y modified cultured allograft that, when applied to a 
wound. would act as a temporary dressing that would sustain the 
local synthesis and sec retion of a wound-hea ling growth f.1ctor. 
Such a cell-based method for the synthesis and delivery of locally 
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acting cycokincs would obviate the need for the large-sca le pm-
duction and purification ofrecombin:ult proteins and could provicir 
a means for the sustained deli very to the wound site of cytokine! 
such as PDGF that have very shOT[ half-lives (~2 min) [41]. 
We gra/liull)' I1Ckll!JlIIit'dgt' Bfrwctl L1IS('//; fi)r ItislOiogic prepnraliolls, Drs. Gm/d 
Knleger alld Lawr(')lct BnJUJ/I.fI." hisw/ilgic cXlllllillaliulIs, alld Dr. Cilarirs StjJrJJ~ 
IlI'lp wi/It tl)e PDCF ')il1l1sslI}" 
This w(ll'k was sIIppm1e11 ill Jlllrt bl' grallts fro m tile NlHimll1l IlISlifllll'S of HI'a/tli 
(POI HDZS5Z8-01 & JU9 AR-I2012-Dlr1 I) aRM), Fritz rhyssc/lll/u{ Gm)ra)1 
Rescarch Fo""dlliioll.{ (SA E), tllIIl ptll1illl SUPIUJ/1 .fmm Illc Slm'"crs Hospiltl/J 101 
C rippled Chihfrfll. 
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ANNOUNCEMENT 
World Wide Wcb addresses for t h ej{Jllm a/, the Society for fn vestigative D ermato logy, and the 
European Society for Dermato logical Rcsearch are now available: 
j""ma/ of [IlIlcstig aN/le Dcmlnt%gy 
http://www.mcd/un c.edu/jid/ 
T he Society fo r Investiga tive Derm atology 
http: //www.telem cdicin e.org/s idh omc. htm 
T he Europcan Socicty for Dcrmatologica l R.esearch 
http://derm Ol.az lJ .kun.n l/www/esdr/csdr.htm 
